Saavedra, Baby Boy .
HRN: 21-72-48 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2022
AMPICILLIN 250MG (VIAL)
08/12/2022
08/18/2022
IV
250mg
Q12
Neonatal Asphyxia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes